Logo image of XELB

XCEL BRANDS INC (XELB) Stock Fundamental Analysis

NASDAQ:XELB - Nasdaq - US98400M1018 - Common Stock - Currency: USD

0.4001  -0.01 (-1.98%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to XELB. XELB was compared to 120 industry peers in the Specialty Retail industry. XELB has a bad profitability rating. Also its financial health evaluation is rather negative. XELB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

XELB had negative earnings in the past year.
In the past year XELB has reported a negative cash flow from operations.
XELB had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: XELB reported negative operating cash flow in multiple years.
XELB Yearly Net Income VS EBIT VS OCF VS FCFXELB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -40.94%, XELB is doing worse than 92.31% of the companies in the same industry.
With a Return On Equity value of -59.89%, XELB is not doing good in the industry: 75.21% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -40.94%
ROE -59.89%
ROIC N/A
ROA(3y)-14.53%
ROA(5y)-11.3%
ROE(3y)-21.38%
ROE(5y)-16.55%
ROIC(3y)N/A
ROIC(5y)N/A
XELB Yearly ROA, ROE, ROICXELB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30 -40

1.3 Margins

The Gross Margin of XELB (93.09%) is better than 99.15% of its industry peers.
XELB's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for XELB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 93.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.17%
GM growth 5Y-7.95%
XELB Yearly Profit, Operating, Gross MarginsXELB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

XELB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XELB has been increased compared to 1 year ago.
The number of shares outstanding for XELB has been increased compared to 5 years ago.
XELB has a worse debt/assets ratio than last year.
XELB Yearly Shares OutstandingXELB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
XELB Yearly Total Debt VS Total AssetsXELB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -2.12, we must say that XELB is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of XELB (-2.12) is worse than 87.18% of its industry peers.
XELB has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of XELB (0.09) is better than 70.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z -2.12
ROIC/WACCN/A
WACC9.36%
XELB Yearly LT Debt VS Equity VS FCFXELB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

XELB has a Current Ratio of 0.52. This is a bad value and indicates that XELB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.52, XELB is doing worse than 95.73% of the companies in the same industry.
XELB has a Quick Ratio of 0.52. This is a bad value and indicates that XELB is not financially healthy enough and could expect problems in meeting its short term obligations.
XELB's Quick ratio of 0.52 is in line compared to the rest of the industry. XELB outperforms 52.14% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
XELB Yearly Current Assets VS Current LiabilitesXELB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

3

3. Growth

3.1 Past

XELB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.95%, which is quite impressive.
The Revenue for XELB has decreased by -52.22% in the past year. This is quite bad
The Revenue for XELB have been decreasing by -12.93% on average. This is quite bad
EPS 1Y (TTM)45.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)-52.22%
Revenue growth 3Y-15.52%
Revenue growth 5Y-12.93%
Sales Q2Q%-27.49%

3.2 Future

XELB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.54% yearly.
Based on estimates for the next years, XELB will show a small growth in Revenue. The Revenue will grow by 2.50% on average per year.
EPS Next Y64.45%
EPS Next 2Y41.42%
EPS Next 3Y28.54%
EPS Next 5YN/A
Revenue Next Year-47.46%
Revenue Next 2Y-4.16%
Revenue Next 3Y2.5%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XELB Yearly Revenue VS EstimatesXELB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
XELB Yearly EPS VS EstimatesXELB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

XELB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XELB Price Earnings VS Forward Price EarningsXELB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XELB Per share dataXELB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as XELB's earnings are expected to grow with 28.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y28.54%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XELB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XCEL BRANDS INC

NASDAQ:XELB (2/5/2025, 4:30:02 PM)

0.4001

-0.01 (-1.98%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-20 2024-12-20/amc
Earnings (Next)N/A N/A
Inst Owners26.91%
Inst Owner Change-10.96%
Ins Owners41.15%
Ins Owner Change0.57%
Market Cap9.46M
Analysts82.86
Price Target1.91 (377.38%)
Short Float %2.65%
Short Ratio2.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.25%
Min EPS beat(2)54.75%
Max EPS beat(2)87.75%
EPS beat(4)4
Avg EPS beat(4)49.84%
Min EPS beat(4)5.88%
Max EPS beat(4)87.75%
EPS beat(8)6
Avg EPS beat(8)26.78%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-11.64%
Max Revenue beat(2)7.72%
Revenue beat(4)1
Avg Revenue beat(4)-3.89%
Min Revenue beat(4)-11.64%
Max Revenue beat(4)7.72%
Revenue beat(8)3
Avg Revenue beat(8)1.49%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.25%
PT rev (3m)-25%
EPS NQ rev (1m)-40%
EPS NQ rev (3m)-250%
EPS NY rev (1m)11.54%
EPS NY rev (3m)11.54%
Revenue NQ rev (1m)-15.53%
Revenue NQ rev (3m)-38.45%
Revenue NY rev (1m)-4.59%
Revenue NY rev (3m)-4.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.01
P/FCF N/A
P/OCF N/A
P/B 0.26
P/tB 7.41
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0.39
BVpS1.56
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.94%
ROE -59.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 93.09%
FCFM N/A
ROA(3y)-14.53%
ROA(5y)-11.3%
ROE(3y)-21.38%
ROE(5y)-16.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.17%
GM growth 5Y-7.95%
F-Score2
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.13%
Cap/Sales 1.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z -2.12
F-Score2
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)7.23%
Cap/Depr(5y)58.14%
Cap/Sales(3y)1.53%
Cap/Sales(5y)6.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y64.45%
EPS Next 2Y41.42%
EPS Next 3Y28.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-52.22%
Revenue growth 3Y-15.52%
Revenue growth 5Y-12.93%
Sales Q2Q%-27.49%
Revenue Next Year-47.46%
Revenue Next 2Y-4.16%
Revenue Next 3Y2.5%
Revenue Next 5YN/A
EBIT growth 1Y44.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.23%
EBIT Next 3Y35.77%
EBIT Next 5YN/A
FCF growth 1Y41.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.61%
OCF growth 3YN/A
OCF growth 5YN/A